Metabolic epilepsy: An update

Laura Papetti, Pasquale Parisi, Vincenzo Leuzzi, Francesca Nardecchia, Francesco Nicita, Fabiana Ursitti, Francesca Marra, Maria Chiara Paolino, Alberto Spalice

Research output: Contribution to journalArticle

Abstract

Inborn errors of metabolism comprise a large class of genetic diseases involving disorders of metabolism. Presentation is usually in the neonatal period or infancy but can occur at any time, even in adulthood. Seizures are frequent symptom in inborn errors of metabolism, with no specific seizure types or EEG signatures. The diagnosis of a genetic defect or an inborn error of metabolism often results in requests for a vast array of biochemical and molecular tests leading to an expensive workup. However a specific diagnosis of metabolic disorders in epileptic patients may provide the possibility of specific treatments that can improve seizures. In a few metabolic diseases, epilepsy responds to specific treatments based on diet or supplementation of cofactors (vitamin-responsive epilepsies), but for most of them specific treatment is unfortunately not available, and conventional antiepileptic drugs must be used, often with no satisfactory success. In this review we present an overview of metabolic epilepsies based on various criteria such as treatability, age of onset, seizure type, and pathogenetic background.

Original languageEnglish
Pages (from-to)827-841
Number of pages15
JournalBrain and Development
Volume35
Issue number9
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Inborn Errors Metabolism
Epilepsy
Seizures
Inborn Genetic Diseases
Metabolic Diseases
Age of Onset
Vitamins
Anticonvulsants
Electroencephalography
Therapeutics
Diet

Keywords

  • Children
  • Encephalopathy
  • Genetics
  • Inherited metabolic disorders
  • Metabolic epilepsy
  • Metabolism

ASJC Scopus subject areas

  • Clinical Neurology
  • Developmental Neuroscience
  • Pediatrics, Perinatology, and Child Health

Cite this

Papetti, L., Parisi, P., Leuzzi, V., Nardecchia, F., Nicita, F., Ursitti, F., ... Spalice, A. (2013). Metabolic epilepsy: An update. Brain and Development, 35(9), 827-841. https://doi.org/10.1016/j.braindev.2012.11.010

Metabolic epilepsy : An update. / Papetti, Laura; Parisi, Pasquale; Leuzzi, Vincenzo; Nardecchia, Francesca; Nicita, Francesco; Ursitti, Fabiana; Marra, Francesca; Paolino, Maria Chiara; Spalice, Alberto.

In: Brain and Development, Vol. 35, No. 9, 10.2013, p. 827-841.

Research output: Contribution to journalArticle

Papetti, L, Parisi, P, Leuzzi, V, Nardecchia, F, Nicita, F, Ursitti, F, Marra, F, Paolino, MC & Spalice, A 2013, 'Metabolic epilepsy: An update', Brain and Development, vol. 35, no. 9, pp. 827-841. https://doi.org/10.1016/j.braindev.2012.11.010
Papetti L, Parisi P, Leuzzi V, Nardecchia F, Nicita F, Ursitti F et al. Metabolic epilepsy: An update. Brain and Development. 2013 Oct;35(9):827-841. https://doi.org/10.1016/j.braindev.2012.11.010
Papetti, Laura ; Parisi, Pasquale ; Leuzzi, Vincenzo ; Nardecchia, Francesca ; Nicita, Francesco ; Ursitti, Fabiana ; Marra, Francesca ; Paolino, Maria Chiara ; Spalice, Alberto. / Metabolic epilepsy : An update. In: Brain and Development. 2013 ; Vol. 35, No. 9. pp. 827-841.
@article{cf800a260ddf4cb1b5cf285d2c10839d,
title = "Metabolic epilepsy: An update",
abstract = "Inborn errors of metabolism comprise a large class of genetic diseases involving disorders of metabolism. Presentation is usually in the neonatal period or infancy but can occur at any time, even in adulthood. Seizures are frequent symptom in inborn errors of metabolism, with no specific seizure types or EEG signatures. The diagnosis of a genetic defect or an inborn error of metabolism often results in requests for a vast array of biochemical and molecular tests leading to an expensive workup. However a specific diagnosis of metabolic disorders in epileptic patients may provide the possibility of specific treatments that can improve seizures. In a few metabolic diseases, epilepsy responds to specific treatments based on diet or supplementation of cofactors (vitamin-responsive epilepsies), but for most of them specific treatment is unfortunately not available, and conventional antiepileptic drugs must be used, often with no satisfactory success. In this review we present an overview of metabolic epilepsies based on various criteria such as treatability, age of onset, seizure type, and pathogenetic background.",
keywords = "Children, Encephalopathy, Genetics, Inherited metabolic disorders, Metabolic epilepsy, Metabolism",
author = "Laura Papetti and Pasquale Parisi and Vincenzo Leuzzi and Francesca Nardecchia and Francesco Nicita and Fabiana Ursitti and Francesca Marra and Paolino, {Maria Chiara} and Alberto Spalice",
year = "2013",
month = "10",
doi = "10.1016/j.braindev.2012.11.010",
language = "English",
volume = "35",
pages = "827--841",
journal = "Brain and Development",
issn = "0387-7604",
publisher = "Elsevier",
number = "9",

}

TY - JOUR

T1 - Metabolic epilepsy

T2 - An update

AU - Papetti, Laura

AU - Parisi, Pasquale

AU - Leuzzi, Vincenzo

AU - Nardecchia, Francesca

AU - Nicita, Francesco

AU - Ursitti, Fabiana

AU - Marra, Francesca

AU - Paolino, Maria Chiara

AU - Spalice, Alberto

PY - 2013/10

Y1 - 2013/10

N2 - Inborn errors of metabolism comprise a large class of genetic diseases involving disorders of metabolism. Presentation is usually in the neonatal period or infancy but can occur at any time, even in adulthood. Seizures are frequent symptom in inborn errors of metabolism, with no specific seizure types or EEG signatures. The diagnosis of a genetic defect or an inborn error of metabolism often results in requests for a vast array of biochemical and molecular tests leading to an expensive workup. However a specific diagnosis of metabolic disorders in epileptic patients may provide the possibility of specific treatments that can improve seizures. In a few metabolic diseases, epilepsy responds to specific treatments based on diet or supplementation of cofactors (vitamin-responsive epilepsies), but for most of them specific treatment is unfortunately not available, and conventional antiepileptic drugs must be used, often with no satisfactory success. In this review we present an overview of metabolic epilepsies based on various criteria such as treatability, age of onset, seizure type, and pathogenetic background.

AB - Inborn errors of metabolism comprise a large class of genetic diseases involving disorders of metabolism. Presentation is usually in the neonatal period or infancy but can occur at any time, even in adulthood. Seizures are frequent symptom in inborn errors of metabolism, with no specific seizure types or EEG signatures. The diagnosis of a genetic defect or an inborn error of metabolism often results in requests for a vast array of biochemical and molecular tests leading to an expensive workup. However a specific diagnosis of metabolic disorders in epileptic patients may provide the possibility of specific treatments that can improve seizures. In a few metabolic diseases, epilepsy responds to specific treatments based on diet or supplementation of cofactors (vitamin-responsive epilepsies), but for most of them specific treatment is unfortunately not available, and conventional antiepileptic drugs must be used, often with no satisfactory success. In this review we present an overview of metabolic epilepsies based on various criteria such as treatability, age of onset, seizure type, and pathogenetic background.

KW - Children

KW - Encephalopathy

KW - Genetics

KW - Inherited metabolic disorders

KW - Metabolic epilepsy

KW - Metabolism

UR - http://www.scopus.com/inward/record.url?scp=84883452270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883452270&partnerID=8YFLogxK

U2 - 10.1016/j.braindev.2012.11.010

DO - 10.1016/j.braindev.2012.11.010

M3 - Article

C2 - 23273990

AN - SCOPUS:84883452270

VL - 35

SP - 827

EP - 841

JO - Brain and Development

JF - Brain and Development

SN - 0387-7604

IS - 9

ER -